Pertussis
📧 Sign up to get email alerts when something new happens for Pertussis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2012-04-17Clinical Trial Update: Study of PENTAXIM™ Vaccine Versus TETRAXIM™ Vaccine Given With ACTHIB™ Vaccine in South Korean Infants. [Phase 3]
A Phase 3 study comparing PENTAXIM with TETRAXIM when co-administered with ACTHIB in South Korean infants has completed.
-
CLINICAL_TRIALS trial_result · 2012-04-17Clinical Trial Update: Immunogenicity and Safety of Pentaxim as 3 Doses Primary Vaccination Followed by a Booster Dose at 18 Months [Phase 3]
Phase 3 trial evaluating immunogenicity and safety of Pentaxim given as three-dose primary vaccination with an 18-month booster.
-
CLINICAL_TRIALS trial_result · 2012-04-16Clinical Trial Update: Assessment of the Immunogenicity and Safety of PENTAXIM™ in Philippines [Phase 4]
Phase 4 clinical trial assessing immunogenicity and safety of PENTAXIM vaccine in the Philippines for diphtheria, tetanus, poliomyelitis, pe…
-
CLINICAL_TRIALS trial_result · 2012-04-16Clinical Trial Update: Immunogenicity and Safety of Pentaxim™ in an Indian Population [Phase 3]
Phase 3 trial evaluated immunogenicity and safety of Pentaxim in an Indian population. The study has completed.
-
CLINICAL_TRIALS trial_result · 2012-04-16Clinical Trial Update: Immunogenicity and Safety of Tetraxim Versus Local DTP + IPV [Phase 3]
Phase 3 trial comparing the immunogenicity and safety of Tetraxim versus local DTP + IPV has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2012-04-16Clinical Trial Update: Immunogenicity and Safety of Sanofi Pasteur Pentaxim Combined Vaccine in Infants in Thailand [Phase 4]
Phase 4 trial assessing immunogenicity and safety of the Sanofi Pasteur Pentaxim combined vaccine in infants in Thailand; the study has comp…
-
CLINICAL_TRIALS trial_result · 2012-03-13Clinical Trial Update: Study of the Environmental Factors Modulating Children Immune Response in Northern Senegal
The trial evaluating environmental factors affecting immune responses in children in Northern Senegal has completed, sponsored by the Biomed…
-
CLINICAL_TRIALS trial_result · 2012-01-31Clinical Trial Update: Study of the Safety, Immunogenicity and Lot Comparability of DAPTACEL When Administered With Other Recommended Vaccine [Phase 3]
Phase 3 trial evaluating safety, immunogenicity, and lot-to-lot comparability of the DTaP vaccine DAPTACEL when administered with other reco…
-
CLINICAL_TRIALS trial_result · 2011-12-13Clinical Trial Update: A Study of DTaP//PRP-T Combined Vaccine (ACTACEL) Versus Local DTaP and Act-HIB Monovalent Vaccine in Healthy Infants [Phase 3]
This Phase 3 trial compares ACTACEL (DTaP-PRP-T) with separate DTaP and Act-HIB vaccines in healthy infants and has completed.
-
CLINICAL_TRIALS trial_result · 2011-12-13Clinical Trial Update: Antibody Persistence in Healthy Children After Primary and Booster DTaP-IPV-Hep B-PRP-T Vaccine or Control Vaccine
A clinical trial update reports antibody persistence in healthy children after primary and booster vaccination with DTaP-IPV-Hep B-PRP-T com…
-
CLINICAL_TRIALS trial_result · 2011-11-07Clinical Trial Update: Pentavalent DTaP-Hep B-IPV [Phase 2]
Phase 2 trial of the pentavalent DTaP-Hep B-IPV vaccine has completed, evaluating protection against diphtheria, hepatitis B, poliomyelitis,…
-
CLINICAL_TRIALS trial_result · 2011-10-05Clinical Trial Update: Immunogenicity and Safety of TETRAXIM™ Given as a Booster Dose at 4 to 6 Years of Age [Phase 4]
Phase 4 study assessing immunogenicity and safety of a TETRAXIM booster given to children aged 4-6 years.
-
CLINICAL_TRIALS trial_result · 2011-09-22Clinical Trial Update: Immunology of Non-specific Effects of Vaccine [Phase 4]
Phase 4 clinical trial evaluating non-specific immunological effects of vaccines has completed.
-
CLINICAL_TRIALS trial_result · 2011-08-23Clinical Trial Update: Study of Menactra® in Children Aged 4 to 6 Years When Administered Concomitantly With a Fifth Dose of DAPTACEL® [Phase 2]
A Phase 2 trial evaluated concomitant administration of Menactra with a fifth dose of DAPTACEL in children aged 4 to 6 years. The study has …
-
CLINICAL_TRIALS trial_result · 2011-07-28Clinical Trial Update: Tdap Vaccination for Infant Caregivers
Clinical trial assessing Tdap vaccination for infant caregivers has completed. The study aims to protect infants from pertussis.
-
CLINICAL_TRIALS trial_result · 2011-04-07Clinical Trial Update: Post-marketing Evaluation of Reactions Following Receipt of Recommended Adolescent Pertussis Vaccine [Phase 4]
Phase 4 post-marketing evaluation of adverse reactions following receipt of the recommended adolescent pertussis vaccine; sponsor is Sanofi …
-
CLINICAL_TRIALS trial_result · 2011-03-29Clinical Trial Update: A Study to Assess the Safety of Adacel® Vaccine [Phase 3]
Phase 3 safety study of Adacel vaccine completed; results were posted in 2011.
-
CLINICAL_TRIALS trial_result · 2011-01-25Clinical Trial Update: Seroprevalence Study of Hepatitis A, Varicella-Zoster, Cytomegalovirus, Herpes Simplex and Bordetella Pertussis
GlaxoSmithKline-sponsored seroprevalence study assessing antibodies to Hepatitis A, Varicella-zoster virus, Cytomegalovirus, Herpes simplex,…
-
CLINICAL_TRIALS trial_result · 2010-12-24Clinical Trial Update: Booster Study of Combined Diphtheria-tetanus-acellular Pertussis Vaccine in Healthy Adults [Phase 3]
A Phase 3 booster study of a combined Diphtheria-tetanus-acellular Pertussis vaccine in healthy adults has completed.
-
CLINICAL_TRIALS trial_result · 2010-12-17Clinical Trial Update: Study of Reduced-antigen-content Acellular Pertussis Vaccine and Diphtheria-Tetanus-Acellular Pertussis Vaccine [Phase 3]
Phase 3 trial update of reduced-antigen-content acellular pertussis vaccine and diphtheria-tetanus-acellular pertussis vaccine. The study ha…
-
CLINICAL_TRIALS trial_result · 2010-12-03Clinical Trial Update: Safety and Immunogenicity of Tdap Vaccine Compared to DTaP Vaccine in Children 4 to 6 Years of Age [Phase 3]
A Phase 3 study comparing safety and immunogenicity of the Tdap vaccine to the DTaP vaccine in children aged 4 to 6 years, with results post…
-
CLINICAL_TRIALS trial_result · 2010-11-10Clinical Trial Update: Safety and Immune Response of Different Pediatric Combination Vaccines. [Phase 3]
Phase 3 clinical trial update reporting safety and immune response of pediatric combination vaccines targeting diphtheria, poliomyelitis, an…
-
CLINICAL_TRIALS trial_result · 2010-10-21Clinical Trial Update: Post-licensure, Modified Double-blind, Multi-center Study Evaluating Safety and Immunogenicity of ADACEL® and BOOSTRIX® [Phase 4]
Phase 4 post-licensure study assessing safety and immunogenicity of ADACEL and BOOSTRIX vaccines across multiple centers.
-
CLINICAL_TRIALS research · 2010-08-27Clinical Trial Update: Pilot Study Freeze and Transport Immune Cells
A completed pilot study funded by NIAID evaluating the freezing and transport of immune cells for vaccines, covering diphtheria, hepatitis B…
-
CLINICAL_TRIALS trial_result · 2010-07-22Clinical Trial Update: Descriptive, Open-label, Multicenter Study of the Safety of Redosing With ADACEL® Vaccine [Phase 4]
Phase 4 open-label multicenter trial assessing safety of redosing with the ADACEL vaccine. Results were posted in 2010.